These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1717096)
41. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). Beemsterboer PM; Kranse R; de Koning HJ; Habbema JD; Schröder FH Int J Cancer; 1999 Aug; 84(4):437-41. PubMed ID: 10404100 [TBL] [Abstract][Full Text] [Related]
42. The diagnostic accuracy of digital rectal examination, transrectal ultrasonography, prostate-specific antigen (PSA) and PSA density in prostate carcinoma. Akdas A; Tarcan T; Türkeri L; Cevik I; Biren T; Gürmen N Br J Urol; 1995 Jul; 76(1):54-6. PubMed ID: 7544205 [TBL] [Abstract][Full Text] [Related]
43. [Yield of ultrasonography-guided transrectal biopsy in the diagnosis of carcinoma of the prostate]. Fernández González I; Ruiz Rubio JL; Llorente Abarca C; Aramburu González JA; Montes Díaz MJ; Herrero Payo A; Sánchez Sánchez E; Berenguer Sánchez A Arch Esp Urol; 1995; 48(6):587-94. PubMed ID: 7544968 [TBL] [Abstract][Full Text] [Related]
44. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view. Deliveliotis C; Alivizatos G; Karayiannis A; Kontothanasis D; Makrychoritis K; Lysiotis P; Dimopoulos MA Br J Urol; 1995 May; 75(5):637-41. PubMed ID: 7542133 [TBL] [Abstract][Full Text] [Related]
45. Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men. Catalona WJ; Richie JP; Ahmann FR; Hudson MA; Scardino PT; Flanigan RC; DeKernion JB; Ratliff TL; Kavoussi LR; Dalkin BL; Waters WB; MacFarlane MT; Southwick PC J Urol; 2017 Feb; 197(2S):S200-S207. PubMed ID: 28012755 [TBL] [Abstract][Full Text] [Related]
46. Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination. Schröder FH; Roobol-Bouts M; Vis AN; van der Kwast T; Kranse R Urology; 2001 Jan; 57(1):83-90. PubMed ID: 11164149 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic testing for prostate cancer detection: less is best. Babaian RJ; Dinney CP; Ramirez EI; Evans RB Urology; 1993 May; 41(5):421-5. PubMed ID: 7683834 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL. Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488 [TBL] [Abstract][Full Text] [Related]
49. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate. Presti JC; Carroll PR Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474 [TBL] [Abstract][Full Text] [Related]
50. A reliable coding system to define screening prostate-specific antigen tests was developed in a case-control study. Bunting PS; Neuman J; Goel V; Fleshner N; Kopec J; Levers P; Warde P J Clin Epidemiol; 2005 Jun; 58(6):639-44. PubMed ID: 15878478 [TBL] [Abstract][Full Text] [Related]
51. Prostate cancer: comparison of digital rectal examination and transrectal ultrasound for screening. Palken M; Cobb OE; Simons CE; Warren BH; Aldape HC J Urol; 1991 Jan; 145(1):86-90; discussion 90-2. PubMed ID: 1701498 [TBL] [Abstract][Full Text] [Related]
52. The risks of prostate cancer detection by transrectal ultrasound guide biopsy in Thai men with abnormal prostatic-specific antigen or abnormal digital rectal examination. Leewansangtong S; Tantiwong A; Ratanarapee S; Nualyong C; Soontrapa S J Med Assoc Thai; 2000 Dec; 83(12):1519-24. PubMed ID: 11253893 [TBL] [Abstract][Full Text] [Related]
53. Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. Ellis WJ; Chetner MP; Preston SD; Brawer MK J Urol; 1994 Nov; 152(5 Pt 1):1520-5. PubMed ID: 7523710 [TBL] [Abstract][Full Text] [Related]
54. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen. Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831 [TBL] [Abstract][Full Text] [Related]
55. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma. Bretton PR; Evans WP; Borden JD; Castellanos RD Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040 [TBL] [Abstract][Full Text] [Related]
56. Predicted prostate specific antigen results using transrectal ultrasound gland volume. Differentiation of benign prostatic hyperplasia and prostate cancer. Lee F; Littrup PJ; Loft-Christensen L; Kelly BS; McHugh TA; Siders DB; Mitchell AE; Newby JE Cancer; 1992 Jul; 70(1 Suppl):211-20. PubMed ID: 1376190 [TBL] [Abstract][Full Text] [Related]
57. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study. Walsh AL; Considine SW; Thomas AZ; Lynch TH; Manecksha RP Br J Gen Pract; 2014 Dec; 64(629):e783-7. PubMed ID: 25452543 [TBL] [Abstract][Full Text] [Related]
58. [Current role of prostatic transrectal ultrasound in the diagnosis of CaP]. Soggia P; Madonia M; Corbu C Urologia; 2012; 79(2):130-4. PubMed ID: 22427243 [TBL] [Abstract][Full Text] [Related]
59. [Diagnosis of localized prostate cancer: screening and preoperative staging]. Hammerer P; Huland H Urologe A; 1991 Nov; 30(6):378-86. PubMed ID: 1722921 [TBL] [Abstract][Full Text] [Related]